Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FDA accepts NDA for once-weekly contraceptive patch

July 4, 2012

DiscoveryBioMed receives funding to support metabolic diseases drug discovery program

July 4, 2012

New agents for hypercholesterolemia designed in Japan

July 2, 2012

Somatuline approved in Japan

July 2, 2012

Mitsubishi Tanabe drug approved for type 2 diabetes

June 29, 2012

Sanwa and Fuji submit application for hyperuricemia and gout treatment in Japan

June 29, 2012

FDA accepts Shionogi NDA for review

June 29, 2012

New notum-directed antibodies may be useful to treat osteoporosis

June 29, 2012

Studies yield encouraging VRS-317 pharmacodynamic and safety data

June 29, 2012

Janssen-Cilag applies for European approval of canagliflozin

June 28, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...